> Alpharma got a green light from the FDA to launch a Phase II trial of an abuse-resistant painkiller. Report
> Emerillon Therapeutics has signed a deal to buy all outstanding shares of HemaX Genome. Article
> Singapore-based SciGen has inked a $145 million-plus deal to supply China with its Hepatitis B vaccine. Report
> Crucell will pocket $1 million and stands to gain much more with Merck's decision to use its production technology to develop a hepatitis C vaccine. Article
> Bangladesh's Beximco Pharmaceuticals became the first drug company in that country to go public on the UK market, raising $21 million. Release
> Micro Therapeutics says that ev3 has offered to buy the 30 percent of shares it doesn't already own. Report
> Agensys has signed a collaboration deal with Sanofi Pasteur to develop new vaccine products directed at colorectal and prostate cancers. Release
And Finally... Researchers are focused on using adult stem cell injections to repair damaged cardiac tissue. Article